155 related articles for article (PubMed ID: 4377134)
1. Clinical evaluation of cinnarizine in hyperlipaemic patients.
Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
[No Abstract] [Full Text] [Related]
2. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
Therapie; 1978; 33(5):615-22. PubMed ID: 217121
[No Abstract] [Full Text] [Related]
3. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
Klemens UH; von Löwis P
Dtsch Med Wochenschr; 1973 Jun; 98(24):1197-202. PubMed ID: 4350685
[No Abstract] [Full Text] [Related]
4. [Beta-sitosterin in unsuccessfully pretreated patients with hypercholesteremia. Simultaneously, a contribution to dose dependence].
Mühlfellner G; Mühlfellner O; Kaffarnik H
Med Klin; 1976 Apr; 71(18):775-8. PubMed ID: 178987
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
Gaertner U; Johannes KJ
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
Haacke H; Parwaresch MR; Mäder C
Med Klin; 1977 Jul; 72(27):1183-7. PubMed ID: 196168
[TBL] [Abstract][Full Text] [Related]
7. [Drug therapy of hyperlipidemias].
Wolfram G
Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700
[No Abstract] [Full Text] [Related]
8. Antilipidemic drugs. Part 6: LF 178 in man. A preliminary note on a multicenter investigation bearing on 393 subjects with pure or mixed forms of hyperlipidemia.
Wülfert B; Majoie B; de Ceaurriz A
Arzneimittelforschung; 1976; 26(5):906-9. PubMed ID: 183789
[TBL] [Abstract][Full Text] [Related]
9. [Laboratory study of dyslipidemias and dyslipoproteinemias].
Mihalache N; Georgescu M
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1974; 26(8):905-13. PubMed ID: 4157095
[No Abstract] [Full Text] [Related]
10. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
Millett F; Sielski J; Stoll H; Alston N; Gail S
PA J; 1976; 6(2):54-9. PubMed ID: 10235781
[No Abstract] [Full Text] [Related]
12. [Effect of the lipid-lowering agent, procetofen, on the makeup of human biliary lipids].
Grandjean EM; Mordasini R; Paumgartner G
Schweiz Med Wochenschr; 1979 Apr; 109(16):601-2. PubMed ID: 219470
[TBL] [Abstract][Full Text] [Related]
13. Does hypolipidemic therapy prevent coronary heart disease?
Rifkind BM; Levy RI
Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
[No Abstract] [Full Text] [Related]
14. [Classification of hyperlipoproteinemias].
Zabel R
Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
[No Abstract] [Full Text] [Related]
15. [Blood lipids and lipoproteins in the age aspect and their role in the development of arteriosclerosis].
Klimov AN
Vestn Akad Med Nauk SSSR; 1980; (3):45-9. PubMed ID: 7395328
[No Abstract] [Full Text] [Related]
16. [Effect of long-term treatment with fenofibrate on serum lipids and lipoproteins in patients with hypercholesterolemia and hypertriglyceridemia].
Sznajderman M
Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1633-7. PubMed ID: 3588382
[No Abstract] [Full Text] [Related]
17. Effect of the extractive heparinoid, glucuronylglucosaminglycan sulfate (3-GS), on human plasma lipids.
Avogaro P; Bittolo BG; Taroni GC; Cazzolato G; Belussi F
Pharmacol Res Commun; 1977 Nov; 9(10):977-86. PubMed ID: 203952
[No Abstract] [Full Text] [Related]
18. Lipid patterns in haemodialysed and transplanted patients.
Ponticelli C; Barbi G; Mecca G; Cantaluppi A; Annoni G; Mauri F; Brancaccio D
Proc Eur Dial Transplant Assoc; 1976; 12():403-11. PubMed ID: 180524
[TBL] [Abstract][Full Text] [Related]
19. Reduction of serum cholesterol in type II hyperlipidaemia by guar gum.
Jenkins DJ; Leeds AR; Slavin B; Mann J; Jepson EM
Proc Nutr Soc; 1977 Dec; 36(3):94A. PubMed ID: 202966
[No Abstract] [Full Text] [Related]
20. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
